scispace - formally typeset
Z

Zhongwei Zhang

Researcher at Huazhong University of Science and Technology

Publications -  11
Citations -  77

Zhongwei Zhang is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 7 publications receiving 38 citations.

Papers
More filters
Journal ArticleDOI

Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K/AKT/mTOR signaling pathway:

TL;DR: LINC00473 might be involved in HCC progression by acting as a miR-29a-3p sponge to upregulate the expression of Robo1 that activates the PI3K/AKT/mTOR signaling pathway, which leads to enhanced cell proliferation, migration, invasion, tumor progression, and metastasis in H CC.
Journal ArticleDOI

Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity

TL;DR: The data suggest that sF GL2 promotes hepatoma growth by attenuating DC activity and subsequent CD8+ T cell cytotoxicity, suggesting sFGL2 as a novel potential therapeutic target for HCC treatment.
Journal ArticleDOI

Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients

TL;DR: Evaluating the effectiveness of plasma perfusion combined with plasma exchange in patients with hepatitis B virus-related ACLF found PP’+ PE treatment significantly reversed organ failures and ameliorated the development of new organ failure and complications, thus reducing mortality risk of patients with HBV-ACLF.
Journal ArticleDOI

Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection.

TL;DR: In this paper, the authors established and validated a nomogram for predicting 30-day mortality of hepatitis B virus-related ACLF (HBV-ACLF) patients with bacterial infection, which may facilitate optimal therapeutic strategies to improve the prognosis of these patients.